Suppr超能文献

亚胺培南对厌氧菌的体外活性。

In vitro activity of imipenem against anaerobic bacteria.

作者信息

Wexler H M, Finegold S M

出版信息

Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S417-25. doi: 10.1093/clinids/7.supplement_3.s417.

Abstract

The in vitro activity of imipenem, metronidazole, clindamycin, moxalactam, and cefoxitin against 203 strains of anaerobic bacteria isolated from patients at the Veterans Administration Wadsworth Medical Center in Los Angeles was studied. Imipenem and metronidazole were the most active agents overall, inhibiting 98% and 99%, respectively, of all anaerobes tested. At breakpoint levels all of the agents tested were very active against anaerobic cocci. Clostridium perfringens, and Bacteroides species other than those of the Bacteroides fragilis group. Imipenem, metronidazole, and clindamycin were the most active agents against the B. fragilis group in this study, although more recent experience with clindamycin indicates less potency. Marked variation among the susceptibility results obtained at various centers may be due to differences in technique, including inoculum size, media, and incubation time. In all instances, however, imipenem has clearly been the most active of the beta-lactam agents.

摘要

对从洛杉矶退伍军人管理局沃兹沃思医疗中心患者中分离出的203株厌氧菌,研究了亚胺培南、甲硝唑、克林霉素、拉氧头孢和头孢西丁的体外活性。总体而言,亚胺培南和甲硝唑是活性最强的药物,分别抑制了所有受试厌氧菌的98%和99%。在折点水平,所有受试药物对厌氧球菌、产气荚膜梭菌以及脆弱拟杆菌群以外的拟杆菌属均具有很强的活性。在本研究中,亚胺培南、甲硝唑和克林霉素是针对脆弱拟杆菌群活性最强的药物,不过最近关于克林霉素的经验表明其效力较低。各中心获得的药敏结果存在显著差异,这可能是由于技术差异,包括接种量、培养基和孵育时间。然而,在所有情况下,亚胺培南显然都是β-内酰胺类药物中活性最强的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验